BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 24, 2006
View Archived Issues
Solid Earnings For Amgen As Aranesp Hits $1B For Quarter
Amgen Inc. soundly beat estimates for the second quarter, led by a boost in product revenue, including a 26 percent increase in sales of the anemia drug Aranesp. (BioWorld Today)
Read More
ViroPharma's Generic Fight Takes On FDA Rule Change
Read More
Survey Points To PDUFA As Reason For Low FDA Morale
Read More
Cleveland BioLabs: $10.2M For Radioprotectant Drugs
Read More
Other News To Note
Read More
Appointments And Advancements
Read More